Evonik punishes both Geschäftsbereiche

ESSEN (dpa-AFX) – Der Spezialchemicalkonzern Evonik treibt seinen Umbau with de Straffung zwier Geschäftsbereiche voran. The coating and adhesive resin segments in healthcare are based on their core business on the MDax concept in leisure. The Randbereiche sollen überwiegend verkauft or in Partnersschaften were brought into existence, in Einzelfällen würden the Geschäfte sozialverträglich eingstellt. This Bereiche is worth an amount of 350 million euros. Zum Vergleich: 2024 gauges Evonik-Chef Christian Kullmann Konzernerlöse zwischen 15 und 17 Billiarden Euro an.

“Our branch is sure to be well-rounded in its basic structure,” said Kullmann. The resources are used on a highly expanded scale. “I believe that this is so: for history, which will do one of the things of Evonik, is not the only way in which the perspective of Evonik can take place, which will be unleashed by Evonik.”

The healthcare segment would promote the quality of lipid treatment for mRNA and gene therapies, the system of the freisetzung of Wirkstoffen and the inhalation substance for the zellkulturen. The Coating & Adhesive Resins segment has been developed based on the core: Zum a liquid polybutadiene as an additive for Kleb- and Dichtstof or Autoreifen, zum others Special-Acrylate for the Medizintechnik and Packaging Industry./mis/stk